Ana Silva-Dias
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 14
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 10
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 8
- Microbiology top 5%
-
- Fungal Infections and Studies 8
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Urinary Tract Infections Management 3
-
- Bacterial biofilms and quorum sensing 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Acácio G. RodriguesCidália Pina‐VazIsabel M. MirandaL. CobradoJoana BrancoMatilde Monteiro‐SoaresMaria Manuel AzevedoSofia Costa‐de‐Oliveira
In The Last Decade
Ana Silva-Dias
29 papers receiving 965 citations
Peers
Comparison fields: 5 of 97
- Infectious Diseases 470
- Molecular Medicine 112
- Applied Microbiology and Biotechnology 38
- Clinical Biochemistry 101
- Microbiology 85
Countries citing papers authored by Ana Silva-Dias
This map shows the geographic impact of Ana Silva-Dias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Silva-Dias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Silva-Dias more than expected).
Fields of papers citing papers by Ana Silva-Dias
This network shows the impact of papers produced by Ana Silva-Dias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Silva-Dias. The network helps show where Ana Silva-Dias may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Silva-Dias, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 3 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 7 | |
| 8 | 2019 | 25 | |
| 9 | 2017 | 53 | |
| 10 | 2017 | 25 | |
| 11 | 2017 | 4 | |
| 12 | 2016 | 30 | |
| 13 | 2015 | 176 | |
| 14 | 2013 | 56 | |
| 15 | 2012 | 61 | |
| 16 | 2012 | 65 | |
| 17 | 2012 | 58 | |
| 18 | 2011 | 16 | |
| 19 | 2009 | 47 | |
| 20 | 2009 | 29 |
About Ana Silva-Dias
Ana Silva-Dias is a scholar working on Molecular Medicine, Clinical Biochemistry and Infectious Diseases, having authored 29 papers that have together received 984 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (14 papers), Antibiotic Resistance in Bacteria (10 papers), Bacterial Identification and Susceptibility Testing (8 papers), Fungal Infections and Studies (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Urinary Tract Infections Management (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Infectious Diseases (470 citations), Molecular Medicine (112 citations) and Applied Microbiology and Biotechnology (38 citations). Ana Silva-Dias has collaborated with scholars based in Portugal, Spain and Ireland. Frequent co-authors include Acácio G. Rodrigues, Cidália Pina‐Vaz, Isabel M. Miranda, L. Cobrado, Joana Branco, Matilde Monteiro‐Soares, Maria Manuel Azevedo, Sofia Costa‐de‐Oliveira, Ana P. Silva and Rafael Cantón. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.